Psoriasis is caused by chronic inflammation of the skin that occurs in various countries. Current therapy is still dominated by long-term anti-inflammatory which causes various side effects. Hypoxic secretome mesenchymal stem cells (SHMSCs) contain soluble molecule bioactive anti-inflammatory cytokines that can suppress inflammation. However, the role of SHMSCs on IL-6 gene expression in psoriasis-like has not been studied until now. The aim of this study was to determine the effect of SH-MSC administration on IL-6 gene expression in Psoriasis-like rats induced by IMQ 100 mg. The research design is an experimental posttest control group design. The experimental subject was divided into four treatment groups consisting of a healthy group (no treatment), positive control group (only IMQ 100 mg), P1 group (SH-MSC therapy 100 μL/kgBW in 100 mg cream) and P2 group (SH-MSCs therapy 200 µL/kgBW in 100 mg cream). P1 and P2 were given SH-MSC topically for 14 days. At the end of the treatment, termination, extraction skin and IL-6 gene expression analysis by qRT-PCR. The results of this study showed that the mean expression of the IL-6 gene in the healthy group was: 1.00±0.00; positive control: 6.16±1.19, P1: 3.06±1.65, P2: 1.06±0.41. Analysis data using Kruskal Wallis test with p<0.05 and Mann Whitney p<0.05 so that there was a significant difference between treatment group. The administration of SH-MSC had a significant effect on improving conditions in psoriasislike model rats as indicated by a decrease in IL-6 gene expression.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.